Early trials of AOD-9604 showed promising results
While many patients tolerate fasting well on GLP-1s, others may need to adjust their fasting window, meal composition, or activity level depending on how their body responds to both
When the LC and ALC results were considered together, the ROC analysis showed that the AUC of patients with MDD and HC was 0.891, the sensitivity was 82.0%, and the specificity was 82.0%
So, this group had a profound like 20% reduction in severe cardiovascular outcomes, which I think is so cool
Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jdar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML